Skip to main content Accessibility help
×
Home

Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina

  • G. FABRICIUS (a1), P. E. BERGERO (a1), M. E. ORMAZABAL (a2), A. L. MALTZ (a3) and D. F. HOZBOR (a2)...

Summary

Due to the current epidemiological situation of pertussis, several countries have implemented vaccination strategies that include a booster dose for adolescents. Since there is still no evidence showing that the adolescent booster has a positive effect on the most vulnerable group represented by infants, it is difficult to universalize the recommendation to include such reinforcement. In this work we present an age-structured compartmental deterministic model that considers the outstanding epidemiological features of the disease in order to assess the impact of the booster dose at age 11 years (Tdap booster) to infants. To this end, we performed different parameterizations of the model that represent distinct possible epidemiological scenarios. The results obtained show that the inclusion of a single Tdap dose at age 11 years significantly reduces the incidence of the disease within this age group, but has a very low impact on the risk group (0–1 year). An effort to improve the coverage of the first dose would have a much greater impact on infants. These results hold in the 18 scenarios considered, which demonstrates the robustness of these conclusions.

  • View HTML
    • Send article to Kindle

      To send this article to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about sending to your Kindle. Find out more about sending to your Kindle.

      Note you can select to send to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be sent to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

      Find out more about the Kindle Personal Document Service.

      Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina
      Available formats
      ×

      Send article to Dropbox

      To send this article to your Dropbox account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Dropbox.

      Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina
      Available formats
      ×

      Send article to Google Drive

      To send this article to your Google Drive account, please select one or more formats and confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your <service> account. Find out more about sending content to Google Drive.

      Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina
      Available formats
      ×

Copyright

Corresponding author

*Author for correspondence: Dr G. Fabricius, Instituto de Investigaciones Fisicoquímicas Teóricas y Aplicadas, Diagonal 113 y 64, Cc. 16, Suc. 4, 1900 La Plata, Argentina. (Email: fabricius@fisica.unlp.edu.ar)

References

Hide All
1.Anon.Pertussis – United States, 1997–2000. Morbidity and Mortality Weekly Report 2002; 51: 7376.
2.WHO.Pertussis vaccines: WHO position paper. Weekly Epidemiological Record 2010; 85: 385400.
3.Baron, S, et al. Epidemiology of pertussis in French hospitals in 1993 and 1994: thirty years after a routine use of vaccination. Pediatric Infectious Disease Journal 1998; 17: 412418.
4.de Melker, HE, et al. Pertussis in The Netherlands: an outbreak despite high levels of immunization with whole-cell vaccine. Emerging Infectious Diseases 1997; 3: 175178.
5.Hozbor, D, et al. Pertussis epidemiology in Argentina: trends over 2004–2007. Journal of Infection 2009; 59: 225231.
6.de Melker, HE, et al. The incidence of Bordetella pertussis infections estimated in the population from a combination of serological surveys. Journal of Infection 2006; 53: 106113.
7.Mooi, FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infection, Genetics and Evolution 2010; 10: 3649.
8.Kallonen, T, He, Q. Bordetella pertussis strain variation and evolution postvaccination. Expert Review of Vaccines 2009; 8: 863875.
9.Wendelboe, AM, et al. Duration of immunity against pertussis after natural infection or vaccination. Pediatric Infectious Disease Journal 2005; 24: S5861.
10.Yih, WK, et al. The increasing incidence of pertussis in Massachusetts adolescents and adults, 1989–1998. Journal of Infectious Disease 2000; 182: 14091416.
11.Forsyth, KD, et al. Prevention of pertussis: recommendations derived from the second Global Pertussis Initiative roundtable meeting. Vaccine 2007; 25: 26342642.
12.CDC.Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months – Advisory Committee on Immunization Practices (ACIP), 2011. Morbidity and Mortality Weekly Reports 2011; 60: 14241426.
13.Anderson, RM, May, RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programmes. Journal of Hygiene 1985; 94: 365436.
14.Grenfell, BT, Anderson, RM. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proceedings of the Royal Society of London, Series B 1989; 236: 213252.
15.Hethcote, HW. An age-structured model for pertussis transmission. Mathematical Biosciences 1997; 145: 89136.
16.van Boven, M, et al. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Mathematical Biosciences 2000; 164: 161182.
17.Luz, PM, et al. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil. Epidemiology and Infection 2006; 134: 850862.
18.Wearing, HJ, Rohani, P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathogens 2009; 5: e1000647.
19.Lavine, JS, King, AA, Bjornstad, ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proceedings of the National Academy of Sciences USA 2011; 108: 72597264.
20.Rohani, P, Zhong, X, King, AA. Contact network structure explains the changing epidemiology of pertussis. Science 2010; 330: 982985.
21.Forsyth, KD, et al. Pertussis immunization in the Global Pertussis Initiative International Region Recommended Strategies and Implementation Considerations. Pediatric Infectious Disease Journal 2005; 24: S93S97.
23.Argentinean Health Ministry database. (http://msal.gov.ar/htm/site/pdf/AnexoVII_PAI-03-09.pdf). Accessed 10 May 2012.
24.Riva Posse, CA, Miceli, IN. Pertussis: its evolution in Argentina at the end of the twentieth century. Medicina (Buenos Aires) 2005; 65: 716.
25.Anderson, R, May, R. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press, 1991.
26.Broutin, H, et al. Large-scale comparative analysis of pertussis population dynamics: periodicity, synchrony, and impact of vaccination. American Journal of Epidemiology 2005; 161: 11591167.
27.Broutin, H, et al. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proceedings of the Royal Society of London, Series B, 2010; 277: 32393245.
28.Van Rie, A, Hethcote, HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22: 31543165.
29.Rozenbaum, MH, et al. Modelling the impact of extended vaccination strategies on the epidemiology of pertussis. Epidemiology and Infection. Published online: 24 November 2011. doi:10.1017/S0950268811002354.
30.Kretzschmar, M, Teunis, PF, Pebody, RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Medicine 2010; 7: e1000291.
31.Mossong, J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Medicine 2008; 5: e74.
32.Hethcote, HW. Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations. Mathematical Biosciences 1999; 158: 4773.
33.Rohani, P, Earn, D, Grenfell, BT. Opposite patterns of synchrony in sympatric disease metapopulations. Science 1999; 286: 968.
34.Simoes, M, Telo da Gama, MM, Nunes, A. Stochastic fluctuations in epidemics on networks. Journal of the Royal Society Interface 2008; 5: 555566.
35.Gonçalves, S, Abramson, G, Gomes, MFC. Oscillations in SIRS model with distributed delays. European Physical Journal B 2011; 81: 363371.
36.Brooks, DA, Clover, R. Pertussis infection in the United States: role for vaccination of adolescents and adults. Journal of the American Board of Family Medicine 2006; 19: 603611.
37.Quinn, HE, McIntyre, PB. The impact of adolescent pertussis immunization, 2004–2009: lessons from Australia. Bulletin of the World Health Organization 2011; 89: 666674.
38.Skoff, TH, et al. Early Impact of the US Tdap vaccination program on pertussis trends. Archives of Pediatrics and Adolescent Medicine 2012; 166: 344349.
39.Jardine, A, et al. Who gives pertussis to infants? Source of infection for laboratory confirmed cases less than 12 months of age during an epidemic, Sydney, 2009. Communicable Diseases Intelligence 2010; 34: 116121.
40.Bisgard, KM, et al. Infant pertussis: who was the source? Pediatric Infectious Disease Journal 2004; 23: 985989.
41.Wendelboe, AM, et al. Transmission of Bordetella pertussis to young infants. Pediatric Infectious Disease Journal 2007; 26: 293299.
42.Lavine, JS, et al. Short-lived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine 2012; 30: 544551.

Keywords

Type Description Title
WORD
Supplementary materials

Fabricius Supplementary Material
Supplementary Material

 Word (929 KB)
929 KB

Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina

  • G. FABRICIUS (a1), P. E. BERGERO (a1), M. E. ORMAZABAL (a2), A. L. MALTZ (a3) and D. F. HOZBOR (a2)...

Metrics

Altmetric attention score

Full text views

Total number of HTML views: 0
Total number of PDF views: 0 *
Loading metrics...

Abstract views

Total abstract views: 0 *
Loading metrics...

* Views captured on Cambridge Core between <date>. This data will be updated every 24 hours.

Usage data cannot currently be displayed